Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213443321> ?p ?o ?g. }
- W4213443321 endingPage "1125" @default.
- W4213443321 startingPage "1125" @default.
- W4213443321 abstract "Mutations in isocitrate dehydrogenase (IDH)1 and its homolog IDH2 are considered an earliest driver genetic event during gliomagenesis, representing now the molecular hallmark of lower-grade gliomas (LGGs). IDH-mutated genes encode for a neomorphic enzyme that converts α-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (2-HG), which accumulates to high concentrations and alters cellular epigenetics and metabolism. Targeting IDH mutations is the first attempt to apply precision oncology in LGGs. Two distinct strategies have been proposed so far and are under intense clinical investigation: (i) reducing the amount of intratumoral 2-HG by directly blocking the function of mutant IDH enzyme; (ii) exploiting the selective epigenetic and metabolic cellular vulnerabilities as a consequence of 2-HG accumulation. The present review describes the physiopathological mechanisms by which IDH mutations lead to tumorigenesis, discussing their prognostic significance and pivotal role in the gliomas diagnostic classification system. We critically review preclinical evidence and available clinical data of first-generation mutant-selective IDH inhibitors and novel IDH-targeted vaccines. Finally, as an alternative and attractive approach, we present the rationale to take advantage of selective 2-HG related epigenetic and metabolic weaknesses. The results of ongoing clinical trials will help us clarify the complex scenario of IDH-targeted therapeutic approaches in gliomas." @default.
- W4213443321 created "2022-02-25" @default.
- W4213443321 creator A5002018880 @default.
- W4213443321 creator A5007047708 @default.
- W4213443321 creator A5021465650 @default.
- W4213443321 creator A5034426119 @default.
- W4213443321 creator A5042987327 @default.
- W4213443321 creator A5062223253 @default.
- W4213443321 creator A5070833456 @default.
- W4213443321 creator A5082045927 @default.
- W4213443321 creator A5083220865 @default.
- W4213443321 creator A5083607769 @default.
- W4213443321 creator A5083865832 @default.
- W4213443321 date "2022-02-22" @default.
- W4213443321 modified "2023-09-25" @default.
- W4213443321 title "Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations" @default.
- W4213443321 cites W1822869875 @default.
- W4213443321 cites W1964001245 @default.
- W4213443321 cites W2002134084 @default.
- W4213443321 cites W2011376261 @default.
- W4213443321 cites W2013020286 @default.
- W4213443321 cites W2040827479 @default.
- W4213443321 cites W2047867594 @default.
- W4213443321 cites W2066640259 @default.
- W4213443321 cites W2079697265 @default.
- W4213443321 cites W2080452140 @default.
- W4213443321 cites W2085293170 @default.
- W4213443321 cites W2105528101 @default.
- W4213443321 cites W2115707319 @default.
- W4213443321 cites W2124514731 @default.
- W4213443321 cites W2126665584 @default.
- W4213443321 cites W2126817554 @default.
- W4213443321 cites W2131860315 @default.
- W4213443321 cites W2141817885 @default.
- W4213443321 cites W2154313451 @default.
- W4213443321 cites W2155106329 @default.
- W4213443321 cites W2158900087 @default.
- W4213443321 cites W2165307233 @default.
- W4213443321 cites W2184483246 @default.
- W4213443321 cites W2192221936 @default.
- W4213443321 cites W2195565943 @default.
- W4213443321 cites W2366536035 @default.
- W4213443321 cites W2411032707 @default.
- W4213443321 cites W2463367156 @default.
- W4213443321 cites W2496785181 @default.
- W4213443321 cites W2582446241 @default.
- W4213443321 cites W2585230893 @default.
- W4213443321 cites W2588147230 @default.
- W4213443321 cites W2596261790 @default.
- W4213443321 cites W2603204749 @default.
- W4213443321 cites W2615603032 @default.
- W4213443321 cites W2623089849 @default.
- W4213443321 cites W2625742115 @default.
- W4213443321 cites W2735344772 @default.
- W4213443321 cites W2765825833 @default.
- W4213443321 cites W2766297389 @default.
- W4213443321 cites W2767975450 @default.
- W4213443321 cites W2770032077 @default.
- W4213443321 cites W2785262117 @default.
- W4213443321 cites W2806682325 @default.
- W4213443321 cites W2878436114 @default.
- W4213443321 cites W2883634139 @default.
- W4213443321 cites W2884857090 @default.
- W4213443321 cites W2890389550 @default.
- W4213443321 cites W2890911268 @default.
- W4213443321 cites W2899903837 @default.
- W4213443321 cites W2947466648 @default.
- W4213443321 cites W2949179770 @default.
- W4213443321 cites W2951388646 @default.
- W4213443321 cites W2956307686 @default.
- W4213443321 cites W2971604281 @default.
- W4213443321 cites W2984475790 @default.
- W4213443321 cites W2988217467 @default.
- W4213443321 cites W2998502354 @default.
- W4213443321 cites W3002439510 @default.
- W4213443321 cites W3013732036 @default.
- W4213443321 cites W3015988344 @default.
- W4213443321 cites W3019769209 @default.
- W4213443321 cites W3034266209 @default.
- W4213443321 cites W3111384264 @default.
- W4213443321 cites W3129761482 @default.
- W4213443321 cites W3137406939 @default.
- W4213443321 cites W3162454602 @default.
- W4213443321 cites W3164133956 @default.
- W4213443321 cites W3170123002 @default.
- W4213443321 cites W3174246647 @default.
- W4213443321 cites W571060166 @default.
- W4213443321 doi "https://doi.org/10.3390/cancers14051125" @default.
- W4213443321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35267433" @default.
- W4213443321 hasPublicationYear "2022" @default.
- W4213443321 type Work @default.
- W4213443321 citedByCount "10" @default.
- W4213443321 countsByYear W42134433212022 @default.
- W4213443321 countsByYear W42134433212023 @default.
- W4213443321 crossrefType "journal-article" @default.
- W4213443321 hasAuthorship W4213443321A5002018880 @default.
- W4213443321 hasAuthorship W4213443321A5007047708 @default.
- W4213443321 hasAuthorship W4213443321A5021465650 @default.